These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 3719630)

  • 1. [Metabolic basis of cardiac insufficiency in cardiomyopathy].
    Gvozdják J; Gvozdjáková A; Bada V; Kucharská J
    Cas Lek Cesk; 1986 May; 125(18):541-4. PubMed ID: 3719630
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic disorders of cardiac muscle in alcoholic and smoke cardiomyopathy.
    Gvozdják J; Gvozdjáková A; Kucharská J; Bada V; Kováliková V; Zachar A
    Cor Vasa; 1989; 31(4):312-20. PubMed ID: 2805706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Smokers' mitochondrial cardiomyopathy].
    Gvozdjáková A; Kucharská J; Bada V; Gvozdják J
    Cas Lek Cesk; 1989 Nov; 128(46):1452-5. PubMed ID: 2620336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary cardiomyopathies and disorders of myocardial energy metabolism: causes or consequences?].
    Duboc D; Toussaint M; Guerin F; Degeorges M
    Arch Mal Coeur Vaiss; 1988 Oct; 81 Spec No():41-5. PubMed ID: 3145724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of smoking on myocardial metabolism.
    Gvozdjăk J; Gvozdjáková A; Kucharská J; Bada V
    Czech Med; 1987; 10(1):47-53. PubMed ID: 3034529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Smoker's cardiomyopathy].
    Gvozdják J; Gvozdjáková A; Kucharská J; Sány L; Bada V; Krutý F
    Vnitr Lek; 1984 Jul; 30(7):649-54. PubMed ID: 6495665
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental lesions of the myocardium: role of alterations of energetic metabolism].
    Anichkov SV; Zavodskaya IS; Moreva EV
    Clin Ter; 1981 Sep; 98(5):473-80. PubMed ID: 6273056
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biochemical mechanisms of hereditary cardiomyopathy development in W/SSM rats].
    Solov'eva NA; Salganik RI; Grishaeva ON; Dikalov SI; Semenov DE
    Biull Eksp Biol Med; 1995 Aug; 120(8):151-4. PubMed ID: 7579271
    [No Abstract]   [Full Text] [Related]  

  • 9. [Energy-dependent changes in the ultrastructure of human cardiomyocyte mitochondria in alcoholic heart disease].
    Sudarikova IuV; Bakeeva LE; Tsyplenkova VG
    Arkh Patol; 1999; 61(2):15-20. PubMed ID: 10412582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiomyopathy and abnormal mitochondrial function.
    Marin-Garcia J; Goldenthal MJ
    Cardiovasc Res; 1994 Apr; 28(4):456-63. PubMed ID: 8181031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Energy metabolism and myocardial ultrastructure in autoimmune cardiomyopathy].
    Popovich MI; Severin VV; Sharov VG
    Biull Eksp Biol Med; 1986 Dec; 102(12):671-4. PubMed ID: 3801617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin status differentially affects energy transduction in cardiac mitochondria from male and female rats.
    Billimoria FR; Katyare SS; Patel SP
    Diabetes Obes Metab; 2006 Jan; 8(1):67-74. PubMed ID: 16367884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoke cardiomyopathy: disturbance of oxidative processes in myocardial mitochondria.
    Gvozdjáková A; Bada V; Sány L; Kucharská J; Krutý F; Bozek P; Trstanský L; Gvozdják J
    Cardiovasc Res; 1984 Apr; 18(4):229-32. PubMed ID: 6713451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adenylate cyclase system and calcium transport in the cardiac muscle of normal rabbits and rabbits with allergic heart damage].
    Grozdova MD; Grigorovich IuA; Zubovskaia AM; Miroshnichenko VP; Sharlova IL
    Vopr Med Khim; 1980; 26(3):415-21. PubMed ID: 7456376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy.
    Cai L; Wang Y; Zhou G; Chen T; Song Y; Li X; Kang YJ
    J Am Coll Cardiol; 2006 Oct; 48(8):1688-97. PubMed ID: 17045908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable prognosis in congestive cardiomyopathy. Role of left ventricular function, alcoholism, and pulmonary thrombosis.
    Koide T; Kato A; Takabatake Y; Iizuka M; Uchida Y; Ozeki K; Morooka S; Makihana M; Serizawa T; Tanaka S; Ohya T; Momomura S; Murao S
    Jpn Heart J; 1980 Jul; 21(4):451-63. PubMed ID: 7420729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dystrophic cardiomyopathy: amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathways.
    Jung C; Martins AS; Niggli E; Shirokova N
    Cardiovasc Res; 2008 Mar; 77(4):766-73. PubMed ID: 18056762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial Diseases and Cardiomyopathies.
    Brunel-Guitton C; Levtova A; Sasarman F
    Can J Cardiol; 2015 Nov; 31(11):1360-76. PubMed ID: 26518446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of mitochondria in sepsis-induced cardiomyopathy.
    Stanzani G; Duchen MR; Singer M
    Biochim Biophys Acta Mol Basis Dis; 2019 Apr; 1865(4):759-773. PubMed ID: 30342158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review: Mitochondrial medicine--cardiomyopathy caused by defective oxidative phosphorylation.
    Fosslien E
    Ann Clin Lab Sci; 2003; 33(4):371-95. PubMed ID: 14584751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.